Aarti Drugs inks pact to acquire 26.25% stake in Pro-Zeal Green Power Six

10 Jan 2025 Evaluate

Aarti Drugs has signed and executed the Share Subscription and Shareholders’ Agreement with Prozeal Green Power (Promoter Company) and Pro-Zeal Green Power Six, a Special Purpose Vehicle (SPV) formed for developing, constructing, operating and maintaining a solar power plant, for acquisition of at least 26.25% Equity Shares of the SPV and Compulsory Convertible Debentures. 

To meet the green energy needs and optimise energy costs, the company will acquire 26.25% equity stake in SPV as per Electricity Laws. The solar power generated by the SPV will be supplied to the company (Aarti Drugs) for its captive consumption. Cost of acquisition is Rs 1.65 crore. The said acquisition is expected to be completed within 30 days from the execution of Share Subscription and Shareholders’ Agreement. 

Aarti Drugs is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science. 


Aarti Drugs Share Price

404.95 -3.35 (-0.82%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×